J. Lipid Res. Did you know there is a large type edition? Click here.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Originally published In Press as doi:10.1194/jlr.M700011-JLR200 on September 3, 2007

Papers In Press, published online ahead of print December 1, 2007
J. Lipid Res., doi:10.1194/jlr.M700011-JLR200
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow All Versions of this Article:
M700011-JLR200v1
48/12/2614    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Grallert, H.
Right arrow Articles by Rathmann, W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Grallert, H.
Right arrow Articles by Rathmann, W.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Journal of Lipid Research, Vol. 48, 2614-2621, December 2007
Copyright © 2007 by American Society for Biochemistry and Molecular Biology

APOA5 variants and metabolic syndrome in Caucasiansboxs

Harald Grallert*, Eva-Maria Sedlmeier*, Cornelia Huth*,{dagger}, Melanie Kolz*, Iris M. Heid*,{dagger}, Christa Meisinger*, Christian Herder§, Klaus Strassburger**, Anke Gehringer{dagger}{dagger}, Markus Haak{dagger}{dagger}, Guido Giani**, Florian Kronenberg{dagger}{dagger}, H-Erich Wichmann*,{dagger}, Jerzy Adamski§§, Bernhard Paulweber***, Thomas Illig1,* and Wolfgang Rathmann**

* Institute of Epidemiology, GSF-National Research Center for Environment and Health, Neuherberg, Germany
{dagger} Institute of Biometry and Epidemiology, University of Munich, Munich, Germany
§ German Diabetes Clinic, German Diabetes Center, Leibniz Institute at Heinrich-Heine-University, Düsseldorf, Germany
** Institute of Biometrics and Epidemiology, German Diabetes Center, Leibniz Institute at Heinrich-Heine-University, Düsseldorf, Germany
{dagger}{dagger} Division of Genetic Epidemiology, Department of Medical Genetics, Molecular and Clinical Pharmacology, Innsbruck Medical University, Innsbruck, Austria
§§ Institute of Experimental Genetics, Genome Analysis Center, GSF-National Research Center for Environment and Health, Neuherberg, Germany
*** First Department of Internal Medicine, St. Johann Spital, Paracelsus Private Medical University, Salzburg, Austria

boxs The online version of this article (available at http://www.jlr.org) contains supplementary data in the form of three tables, one figure.

Published, JLR Papers in Press, September 3, 2007.

1 To whom correspondence should be addressed. e-mail: illig{at}gsf.de

Apolipoprotein A5 (APOA5) gene variants were reported to be associated with two components of metabolic syndrome (MetS): higher TG levels and lower HDL levels. Moreover, a recent Japanese case-control study found variant –1131T>C associated with MetS itself. Thus, our study systematically analyzed the APOA5 gene for association with lipid parameters, any other features of MetS, including waist circumference, glucose-related parameters, blood pressure, uric acid, and MetS itself in Caucasians. Ten polymorphisms were analyzed in a large fasting sample of the population-based Cooperative Health Research in the Region of Augsburg (KORA) survey S4 (n = 1,354; southern Germany) and in a second fasting sample, the Salzburg Atherosclerosis Prevention Program in Subjects at High Individual Risk (SAPHIR) study (n = 1,770; Austria). Minor alleles of variants –1131T>C, –3A>G, c.56C>G, 476G>A, and 1259T>C were significantly associated with higher TG levels in single polymorphism (P < 0.001) and haplotype (P <= 6.6 x 10–6) analysis. Besides associations with lower HDL levels in SAPHIR (P <= 0.001), there were no significant findings with any other features of MetS. Variant c.56C>G was associated with higher risk for MetS [odds ratio (95% confidence interval) = 1.43 (1.04, 1.99), P = 0.03 for KORA and 1.48 (1.10, 1.99), P = 0.009 for SAPHIR). Our study confirms the association of the APOA5 locus with TG and HDL levels in humans. Furthermore, the data suggest a different mechanism of APOA5 impact on MetS in Caucasians, as variant c.56C>G (not analyzed in the Japanese study) and not –1131T>C, as in the Japanese subjects, was associated with MetS.

Supplementary key words apolipoprotein • polymorphism • Cooperative Health Research in the Region of Augsburg • Salzburg Atherosclerosis Prevention Program in Subjects at High Individual Risk • genetics • lipids • haplotypes • Apolipoprotein A5


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 J. Lipid Res.Home page
Y. Lu, M. E. T. Dolle, S. Imholz, R. van 't Slot, W. M. M. Verschuren, C. Wijmenga, E. J. M. Feskens, and J. M. A. Boer
Multiple genetic variants along candidate pathways influence plasma high-density lipoprotein cholesterol concentrations
J. Lipid Res., December 1, 2008; 49(12): 2582 - 2589.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Journal of Biological Chemistry 
 Molecular and Cellular Proteomics   ASBMB Today 
Copyright © 2007 by the American Society for Biochemistry and Molecular Biology.